tiprankstipranks
BioVie (BIVI)
NASDAQ:BIVI
US Market

BioVie (BIVI) Income Statement

250 Followers

BioVie Income Statement

Last quarter (Q2 2024), BioVie's total revenue was $―, a decrease of ― from the same quarter last year. In Q2, BioVie's net income was $-8.40M. See BioVie’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Jun 23Jun 22Jun 21Jun 20Jun 19
Total Revenue
---$ 0.00$ 0.00$ 0.00
Cost of Revenue
------
Gross Profit
------
Operating Expense
$ 5.88M$ 45.08M$ 27.25M$ 138.05M$ 2.69M$ 2.50M
Operating Income
$ -5.88M$ -45.08M$ -27.25M$ -138.05M$ -2.69M$ -2.50M
Net Non Operating Interest Income Expense
$ -244.46K$ -3.74M$ -2.12M$ -537.48K$ -4.77M$ 886.00
Other Income Expense
$ -2.06M$ -1.44M$ -3.29M$ 8.34M$ -9.21M$ 51.40K
Pretax Income
$ -4.05M$ -50.26M$ -26.08M$ -130.25M$ -16.68M$ -2.44M
Tax Provision
------
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -4.05M$ -50.26M$ -26.08M$ -183.85M$ -33.78M$ -2.49M
Basic EPS
$ -0.94$ -1.55$ -1.06$ -14.82$ -6.85$ -0.98
Diluted EPS
$ -0.94$ -1.55$ -1.06$ -14.82$ -6.85$ -0.98
Basic Average Shares
$ 110.24M$ 32.48M$ 24.66M$ 12.40M$ 4.93M$ 2.54M
Diluted Average Shares
$ 110.24M$ 32.48M$ 24.66M$ 12.40M$ 4.93M$ 2.54M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 5.88M$ 45.08M$ 27.25M$ 138.05M$ 2.69M$ 2.50M
Net Income From Continuing And Discontinued Operation
$ -34.15M$ -50.26M$ -26.08M$ -130.25M$ -16.68M$ -2.44M
Normalized Income
$ -18.92M--$ -138.59M$ -7.47M$ -2.50M
Interest Expense
---$ 559.46K$ 4.77M$ 273.00
EBIT
$ -3.13M$ -45.96M$ -23.92M$ -129.69M$ -11.90M$ -2.44M
EBITDA
$ -3.03M$ -45.73M$ -23.59M$ -129.46M$ -11.67M$ -2.21M
Currency in USD

BioVie Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis